B. Havsteen, The biochemistry and medical significance of the flavonoids, Pharmacology & Therapeutics, vol.96, issue.2-3, pp.67-202, 2002.
DOI : 10.1016/S0163-7258(02)00298-X

S. Hill, K. Williams, and J. Denekamp, Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour action, European Journal of Cancer and Clinical Oncology, vol.25, issue.10, pp.1419-1443, 1989.
DOI : 10.1016/0277-5379(89)90099-0

M. Lopez-lazaro, Flavonoids as Anticancer Agents: Structure-Activity Relationship Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.2, issue.6, pp.691-714, 2002.
DOI : 10.2174/1568011023353714

E. Middleton, J. Kandaswami, C. Theoharides, and T. , The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol Rev, vol.52, pp.673-751, 2000.

Y. Arai, S. Watanabe, M. Kimira, K. Shimoi, R. Mochizuki et al., Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration, J Nutr, vol.130, pp.2243-50, 2000.

M. Kimira, Y. Arai, K. Shimoi, and S. Watanabe, Japanese Intake of Flavonoids and Isoflavonoids from Foods, Journal of Epidemiology, vol.8, issue.3, pp.168-75, 1998.
DOI : 10.2188/jea.8.168

N. Khan, M. Asim, F. Afaq, Z. Abu, and H. Mukhtar, A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice, Cancer Research, vol.68, issue.20, pp.8555-63, 2008.
DOI : 10.1158/0008-5472.CAN-08-0240

R. Tripathi, T. Samadder, S. Gupta, A. Surolia, and C. Shaha, Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors, Molecular Cancer Therapeutics, vol.10, issue.2, pp.255-68, 2011.
DOI : 10.1158/1535-7163.MCT-10-0606

Y. Touil, J. Seguin, D. Scherman, and G. Chabot, Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice, Cancer Chemotherapy and Pharmacology, vol.122, issue.2, 2010.
DOI : 10.1007/s00280-010-1505-8

URL : https://hal.archives-ouvertes.fr/hal-00640237

O. Woodman and E. Chan, VASCULAR AND ANTI-OXIDANT ACTIONS OF FLAVONOLS AND FLAVONES, Clinical and Experimental Pharmacology and Physiology, vol.66, issue.11, pp.786-90, 2004.
DOI : 10.1046/j.1365-2168.1998.00787.x

Y. Touil, A. Fellous, D. Scherman, and G. Chabot, Flavonoid-Induced Morphological Modifications of Endothelial Cells Through Microtubule Stabilization, Nutrition and Cancer, vol.57, issue.3, pp.310-331, 2009.
DOI : 10.1006/exer.2000.0900

URL : https://hal.archives-ouvertes.fr/inserm-00564663

T. Fotsis, M. Pepper, E. Aktas, S. Breit, S. Rasku et al., Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis, Cancer Res, vol.57, pp.2916-2937, 1997.

W. Lee, S. Shen, H. Lin, W. Hou, L. Yang et al., Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca2+-dependent endonuclease, Biochemical Pharmacology, vol.63, issue.2, pp.225-261, 2002.
DOI : 10.1016/S0006-2952(01)00876-0

S. Kuntz, U. Wenzel, and H. Daniel, Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines, European Journal of Nutrition, vol.38, issue.3, pp.133-175, 1999.
DOI : 10.1007/s003940050054

Y. Chen, S. Shen, W. Lee, H. Lin, C. Ko et al., Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1, Archives of Toxicology, vol.76, issue.5-6, pp.351-360, 2002.
DOI : 10.1007/s00204-002-0346-6

A. Haddad, V. Venkateswaran, L. Viswanathan, S. Teahan, N. Fleshner et al., Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines, Prostate Cancer and Prostatic Diseases, vol.12, issue.1, pp.68-76, 2006.
DOI : 10.1016/j.cbi.2004.04.004

X. Lu, J. Jung, H. Cho, D. Lim, H. Lee et al., Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells, J Nutr, vol.135, pp.2884-90, 2005.

B. Sung, M. Pandey, and B. Aggarwal, Fisetin, an Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-??B-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products through the Suppression of TAK-1 and Receptor-Interacting Protein-Regulated I??B?? Kinase Activation, Molecular Pharmacology, vol.71, issue.6, pp.1703-1717, 2007.
DOI : 10.1124/mol.107.034512

H. Lu, D. Chang, B. Baratte, L. Meijer, and U. Schulze-gahmen, Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin, Journal of Medicinal Chemistry, vol.48, issue.3, pp.737-780, 2005.
DOI : 10.1021/jm049353p

A. Olaharski, S. Mondrala, and D. Eastmond, Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.582, issue.1-2, pp.79-86, 2005.
DOI : 10.1016/j.mrgentox.2005.01.002

A. Constantinou, R. Mehta, C. Runyan, K. Rao, A. Vaughan et al., Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships, Journal of Natural Products, vol.58, issue.2, pp.217-242, 1995.
DOI : 10.1021/np50116a009

J. Jankun, S. Selman, J. Aniola, and E. Skrzypczak-jankun, Nutraceutical inhibitors of urokinase: Potential applications in prostate cancer prevention and treatment, Oncology Reports, vol.16, pp.341-347, 2006.
DOI : 10.3892/or.16.2.341

M. Böhl, S. Tietze, A. Sokoll, S. Madathil, F. Pfennig et al., Flavonoids Affect Actin Functions in Cytoplasm and Nucleus, Biophysical Journal, vol.93, issue.8, pp.2767-80, 2007.
DOI : 10.1529/biophysj.107.107813

A. Salmela, J. Pouwels, A. Varis, A. Kukkonen, P. Toivonen et al., Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint, Carcinogenesis, vol.30, issue.6, pp.1032-1072, 2009.
DOI : 10.1093/carcin/bgp101

A. Joussen, K. Rohrschneider, J. Reichling, B. Kirchhof, and F. Kruse, Treatment of Corneal Neovascularization with Dietary Isoflavonoids and Flavonoids, Experimental Eye Research, vol.71, issue.5, pp.483-490, 2000.
DOI : 10.1006/exer.2000.0900

M. Gibaldi and D. Perrier, Noncompartmental Analysis Based on Statistical Moment Theory, J.Swarbrick. Pharmacokinetics, pp.409-426, 1982.
DOI : 10.1201/b14095-12

M. Stefova, T. Stafilov, S. Kulevanova, G. Stefkov, and V. Bankova, QSRR of Flavones: Evaluation of Substituent Contributions to RP HPLC Retention, Journal of Liquid Chromatography & Related Technologies, vol.30, issue.8, pp.1035-1084, 2007.
DOI : 10.1080/10826070601128402

M. Abramoff, P. Magelhaes, and S. Ram, Image processing with ImageJ, Biophotonics International, vol.11, pp.36-42, 2004.

G. Chabot, M. Bissery, T. Corbett, K. Rutkowski, and L. Baker, Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975

C. Shia, S. Tsai, S. Kuo, Y. Hou, and P. Chao, Metabolism and Pharmacokinetics of 3,3???,4???,7-Tetrahydroxyflavone (Fisetin), 5-Hydroxyflavone, and 7-Hydroxyflavone and Antihemolysis Effects of Fisetin and Its Serum Metabolites, Journal of Agricultural and Food Chemistry, vol.57, issue.1, pp.83-92, 2009.
DOI : 10.1021/jf802378q

M. Piskula, Factors affecting flavonoids absorption, BioFactors, vol.215, issue.1-4, pp.175-80, 2000.
DOI : 10.1002/biof.5520120128

T. Myöhänen and P. Männistö, Distribution and Functions of Catechol-O-Methyltransferase Proteins, Int Rev Neurobiol, vol.95, pp.29-47, 2010.
DOI : 10.1016/B978-0-12-381326-8.00003-X

C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez, Polyphenols: food sources and bioavailability, Am J Clin Nutr, vol.79, pp.727-774, 2004.

T. Mabry, K. Markham, and M. Thomas, The systematic identification of flavonoids, 1970.
DOI : 10.1007/978-3-642-88458-0

K. Markham, Techniques of flavonoid identification, 1982.

N. Hevir, J. Sinkovec, and T. Rizner, Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: Lower levels of CYP1B1 and increased expression of S-COMT, Molecular and Cellular Endocrinology, vol.331, issue.1, pp.158-67, 2011.
DOI : 10.1016/j.mce.2010.09.011

URL : https://hal.archives-ouvertes.fr/hal-00639772

L. Dobrossy, Z. Pavelic, M. Vaughan, N. Porter, and R. Bernacki, Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis, Cancer Res, vol.40, pp.3281-3286, 1980.

X. Wen and T. Walle, Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability, Drug Metabolism and Disposition, vol.34, issue.10, pp.1786-92, 2006.
DOI : 10.1124/dmd.106.011122

Y. Lin, S. Hsiu, Y. Hou, H. Chen, and P. Chao, Degradation of Flavonoid Aglycones by Rabbit, Rat and Human Fecal Flora, Biological & Pharmaceutical Bulletin, vol.26, issue.5, pp.747-51, 2003.
DOI : 10.1248/bpb.26.747

S. Fang, Y. Hou, W. Chang, S. Hsiu, P. Chao et al., Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock, Life Sciences, vol.74, issue.6, pp.743-56, 2003.
DOI : 10.1016/j.lfs.2003.07.017

L. Meng, U. Shankavaram, C. Chen, K. Agama, H. Fu et al., Activation of Aminoflavone (NSC 686288) by a Sulfotransferase Is Required for the Antiproliferative Effect of the Drug and for Induction of Histone ??-H2AX, Cancer Research, vol.66, issue.19, pp.9656-64, 2006.
DOI : 10.1158/0008-5472.CAN-06-0796

S. Lotito, W. Zhang, C. Yang, A. Crozier, and B. Frei, Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties, Free Radical Biology and Medicine, vol.51, issue.2, 2011.
DOI : 10.1016/j.freeradbiomed.2011.04.032

S. Tribolo, F. Lodi, C. Connor, S. Suri, V. Wilson et al., Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells, Atherosclerosis, vol.197, issue.1, pp.50-56, 2008.
DOI : 10.1016/j.atherosclerosis.2007.07.040

D. Jones, J. Lamb, R. Verschoyle, L. Howells, M. Butterworth et al., Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity, British Journal of Cancer, vol.77, pp.1213-1222, 2004.
DOI : 10.1038/sj.bjc.6602091

C. Manach, C. Morand, V. Crespy, C. Demigne, O. Texier et al., Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties, FEBS Letters, vol.43, issue.3, pp.331-337, 1998.
DOI : 10.1016/S0014-5793(98)00367-6

A. Day, Y. Bao, M. Morgan, and G. Williamson, Conjugation position of quercetin glucuronides and effect on biological activity, Free Radical Biology and Medicine, vol.29, issue.12, pp.1234-1277, 2000.
DOI : 10.1016/S0891-5849(00)00416-0